Willow Review: Questions to Settle Before Starting a GLP-1 Subscription

Before enrolling with Willow, ask for more than a monthly price: ask which formulation you would receive, who would prescribe and prepare it, and when another payment would be processed. Willow’s public documentation describes a telehealth weight-management platform with compounded semaglutide and tirzepatide, physician review and home delivery. But its general offer does not settle every patient’s prescription, pharmacy assignment or financial responsibility. Those details matter more than whether the headline price looks straightforward.

This documentary review examines Willow’s public pages consulted October 19, 2026, as preparation for a patient conversation—not as a recommendation for individual treatment. There is useful specificity here, including formulation-dependent prices, eligibility exclusions and pharmacy processing times. There are also important unresolved points, particularly contradictory insurance-reimbursement language and incomplete access to separate subscription policies. Our starting questions guide provides a broader checklist; below, the emphasis is on what Willow itself documents and what to ask next.

At a glance

Business model: Willow Health Services, Inc. describes itself as a technology platform connecting patients with physicians and pharmacies, not as the healthcare provider or pharmacy.
Sources: [4]
Medication options: Willow documents compounded semaglutide and tirzepatide in injectable and oral sublingual forms, plus a combination oral-dissolving tablet.
Sources: [6] [10]
Published monthly prices: GLP-1 plans start at $299 per month, but the detailed schedule reaches $549 per month for a specified tirzepatide injectable presentation.
Sources: [6] [3]
Eligibility and location: Published requirements include age 18 or older, not being pregnant or breastfeeding, and a supported location. Willow says it currently cannot accept people with diabetes.
Sources: [5] [4]
Renewal deadline: Programs renew automatically. The FAQ requires cancellation requests at least two business days before the next processing date to avoid the next charge.
Sources: [6]

Start with the exact medicine, not just the GLP-1 label

Willow’s product choices make the prescription question unusually important. Its semaglutide page describes a compounded injection and also describes a blend containing cyanocobalamin, or vitamin B12. Its tirzepatide page describes a customized compounded formulation developed with the prescribing physician. The FAQ adds injectable and oral sublingual options. Ask for the medication’s complete name, ingredients, route and presentation in writing; the presence of one blend on a product page does not establish the composition of every prescription.

The safety documentation separately identifies an oral-dissolving tablet combining semaglutide and tirzepatide. Willow acknowledges that there are no established safety data on this combination beyond what is known about the individual ingredients. Its help center also states that no FDA-approved oral-dissolving formulation of either ingredient exists and that Willow is not the manufacturer. These disclosures make a combination tablet a distinct discussion, not simply another way to purchase an injection.

FDA explains that compounded preparations are not FDA approved and do not receive its premarket review for safety, effectiveness and quality. That status alone does not establish clinical inequivalence. FDA recommends compounded drugs when an individual’s medical needs cannot be met by an approved drug. Ask the prescriber to explain the reason for the proposed preparation and the evidence relevant to its route and ingredients. Our medication questions guide can help organize that conversation.

Sources: [7] [11] [6] [10] [3] [1]

Ask who is responsible for each part of care

The operating entity identified in the terms is Willow Health Services, Inc., with a Houston address. Those terms distinguish the platform from medical and pharmacy services: physicians employed or contracted by affiliated medical practices provide consultations, while pharmacies dispense prescribed medication. Willow says it neither owns those practices nor controls their practice of medicine. For a prospective patient, the practical question is which legal medical practice and individual prescriber will actually be responsible for the consultation.

Willow’s institutional page introduces Michael Green as its chief medical officer and describes him as a dual board-certified physician with more than 30 years of experience. That is a provider statement, not independent credential verification or confirmation that he would treat a particular patient. The consulted documentation does not identify the affiliated medical practices by legal name. Request the treating professional’s name and the practice’s contact information rather than assuming the executive named on the website will oversee your case.

The terms list several pharmacy partners: Red Rock Home Pharmacy in Springville, Utah; Epiq Pharmacy in Richardson, Texas; Absolute Pharmacy in Lutz, Florida; The Pharmacy Hub in Miami; Empower Pharmacy in Houston; and Red Rock Pharmacy in St. George, Utah. The list does not establish which one would fill a particular prescription. Ask for that assignment, the pharmacy’s contact details and who handles questions about ingredients, labeling, packaging or a replacement shipment.

Sources: [4] [9]

Clarify screening before treating payment as acceptance

Willow’s published baseline requirements include being at least 18, not currently pregnant or breastfeeding, and residing in a supported state. Its exclusion list includes an eating disorder, recent bariatric surgery, gallbladder disease, pancreatitis, and a history of medullary thyroid cancer or Multiple Endocrine Neoplasia Type 2. Willow also says it currently cannot accept individuals with diabetes, while people with prediabetes or hypertension are welcome to be considered. These are Willow’s service criteria, not a complete guide to individual medical suitability.

The provider expressly says its list is not exhaustive and that physicians evaluate eligibility individually. Intake begins with an online form covering health, lifestyle and medical history. A physician reviews that information and prescribes only if appropriate; the homepage says review usually occurs within 24 hours. The terms add an important boundary: completing intake, registering, paying or subscribing does not guarantee a prescription, a particular medication, a refill or continued availability.

The FAQ lists 36 supported states rather than nationwide service. The terms also require the patient to be physically located where the applicable medical practice, physician and pharmacy are authorized to provide the relevant services. Ask how travel or relocation affects consultations and refills. The documentation reviewed does not establish a Willow-specific BMI threshold or complete mandatory laboratory protocol, so ask what additional information, testing or appointments may be required before any prescription decision.

Sources: [5] [6] [8] [4]

Get a prescription-specific monthly quote

Willow advertises plans starting at $299 per month, including personalized GLP-1 medication, medical evaluation, a treatment plan, unlimited physician access, Care Team support and shipping. It also says medication costs vary by prescription and dosage. The detailed schedule below is therefore more useful than a single headline number. The amounts and strengths are reproduced as pricing identifiers, not instructions for taking medication or a basis for comparing equivalent exposure across routes.

Ask Willow to confirm the first charge, the renewal amount, the billing date and exactly what quantity and supplies accompany each payment. The documented prices use “month,” not four weeks, and the available material does not establish an exact supply quantity, a prepaid package or a minimum commitment. A separate $199 monthly offer concerns compounded injectable NAD+, not a $199 GLP-1 plan. Do not use that lower number when budgeting for semaglutide or tirzepatide.

The bundled offer also has a pharmacy-channel boundary. Willow says it can send a prescription to a preferred outside pharmacy only if that pharmacy can fill the compound precisely as written. A platform fee then applies, and the patient pays the pharmacy directly for medication. That fee is not quantified in the consulted material. Before switching, request both charges rather than assuming the usual bundled monthly price still applies; our price questions checklist covers other useful quote details.

Willow’s published compounded GLP-1 monthly pricing; strengths identify listed presentations, not patient dosing instructions.
Formulation and route	Listed presentation	Published monthly price
Semaglutide oral-dissolving tablet	All dosages	$299
Tirzepatide oral-dissolving tablet	6 mg or 10 mg; 20 mg	$399; $459, respectively
Semaglutide/tirzepatide combination oral-dissolving tablet	12 mg/10 mg; 24 mg/20 mg	$399; $459, respectively
Semaglutide injectable	All dosages up to 3.5 mg; 7 mg	$299; $399, respectively
Tirzepatide injectable	2.125, 4.25 or 6.375 mg; 8.5 or 11 mg; 13.5 mg; 17 mg	$399; $499; $524; $549, respectively

Sources: [6] [3]

Resolve the insurance contradiction before relying on reimbursement

Willow says it does not bill insurance directly. Its help center nevertheless suggests that patients can pay out of pocket and submit receipts for possible reimbursement, depending on their private or employer-designated plan and deductible. Separately, the FAQ says patients can use an HSA or FSA at checkout for prescriptions. Those are different payment questions: the ability to use an account at checkout does not resolve whether an insurer will reimburse a claim.

The terms contain materially different language. They say patients are solely responsible for purchased services and products, that no reimbursement claims will be submitted on their behalf, and that patients agree not to submit claims to federal or state healthcare programs or other third-party payors. That last category is broader than government insurance alone. The consulted documentation does not resolve how this restriction fits with the help center’s suggestion about submitting receipts to private insurance.

If reimbursement affects affordability, ask Willow for written clarification of which provision applies before enrolling, and separately ask the health plan what it would require. Do not budget as though reimbursement is assured or interpret HSA/FSA acceptance as an insurance-coverage promise. This is not merely a missing estimate: two public descriptions point in different directions. Until reconciled, the clearest documented financial expectation is that the patient remains responsible for the charges.

Sources: [6] [3] [4]

Separate medical review, pharmacy processing and delivery

The detailed delivery explanation begins after identity verification, medical-history review and prescription writing. Willow then sends the order to a partner pharmacy. Pharmacy processing takes two to four business days, followed by home delivery typically taking two to three days through FedEx or UPS. Willow notes that high-volume periods can extend the timeline. Its homepage also describes shipment tracking and discreet packaging, which are useful features but do not shorten the preceding clinical and pharmacy steps.

Read those stages alongside advertising about same-day review or prescriptions and free two-day shipping. Neither establishes arrival two days after registration. Physician review is not dispensing, and shipment dispatch is not delivery. Before scheduling around a first shipment or refill, ask when the pharmacy expects to receive the prescription, when tracking becomes available and who investigates delays. The documentation does not provide a patient-specific arrival guarantee or establish that every order follows the fastest advertised timeline.

Also ask the assigned pharmacy for storage and delivery-problem instructions specific to the dispensed product. FDA explicitly advises against using an injectable GLP-1 drug that arrives warm or with insufficient refrigeration and recommends contacting the provider or dispensing pharmacy. That is a concrete boundary, not a reason to improvise with the shipment. Clarify whom to contact and how a replacement decision is handled before a delivery problem occurs.

Sources: [8] [6] [1]

Define what ongoing support means in practice

Willow advertises fully online care, free regular follow-ups and unlimited physician messaging through the patient portal. Its FAQ says patients typically see the same physician, with exceptions for vacations or staffing changes. The advertised support package also includes video guides and a peer community. These are identifiable service features, but “regular” does not specify a clinical schedule. Ask when follow-ups occur, whether they are initiated by the team and what information the prescriber reviews before renewing treatment.

The FAQ directs general support questions to website chat or email and says the Patient Care Team responds within 24 hours. Elsewhere, Willow advertises 24/7 online Care Team support. Continuous access to a messaging channel should not be read as a promise of an immediate physician response. Ask how administrative questions are distinguished from medication concerns, what the physician response target is, and what instructions apply when a concern cannot wait for a portal reply.

Willow’s semaglutide page says the physician may prescribe generic ondansetron if needed for nausea; it does not establish that this optional medication’s cost is included. Ask about any separate prescription or pharmacy charge rather than assuming every related service falls inside the monthly bundle. NIDDK describes follow-up as attention to response and tolerability, not just ongoing payment. That makes a clear clinical follow-up process more useful than an undefined promise of access.

Sources: [8] [6] [9] [7] [2]

Put the next processing date on your decision checklist

Willow’s program renews automatically. Although the FAQ says patients can cancel anytime by messaging the Patient Care Team, avoiding the next charge requires a request at least two business days before the next processing date. Requests after that cutoff apply to the next cycle. Ask for the actual processing date rather than assuming it matches the delivery date, and retain the cancellation message and confirmation. Our renewal questions guide offers a practical checklist for that exchange.

Refund eligibility is a separate question from stopping renewal. The FAQ offers a full refund if cancellation occurs before the prescription is sent to the pharmacy and describes a five-to-ten-business-day refund window. Do not assume that bank availability is guaranteed within that period. Once pharmacy transmission has occurred, that stated refund condition is no longer satisfied; the consulted documentation does not establish a comparable blanket refund promise for later cancellation.

The terms also refer to separate subscription, return and shipping policies whose complete texts were not available in the consulted material, and say pharmaceutical products are nonreturnable unless legally required. Before paying, request the applicable policies and ask how a denied prescription, an already-transmitted order, a shipment problem or a requested pause is handled. A monthly price and an ability to cancel do not, by themselves, answer those questions or establish a refund entitlement.

Sources: [6] [4]

Questions & answers

Is every Willow GLP-1 prescription $299 per month?

No. That is the advertised starting price. The detailed schedule lists semaglutide oral-dissolving tablets at $299 monthly, while injectable semaglutide and both tirzepatide routes have presentation-dependent prices. Injectable tirzepatide reaches $549 monthly in the listed schedule. Ask for a quote naming the exact formulation, presentation and renewal amount rather than relying on the general starting price.

Sources: [6] [3]

Does Willow offer only injections?

No. Willow documents injectable and oral sublingual forms, including oral-dissolving tablets and a combined semaglutide/tirzepatide tablet. The help center says there is no FDA-approved oral-dissolving formulation of either ingredient. Willow’s safety page also acknowledges that established safety data for the combination do not extend beyond what is known for the ingredients individually. Ask about the specific preparation, not just the ingredient names.

Sources: [6] [3] [10]

Can I join Willow if I have diabetes?

Willow’s eligibility page says it currently cannot accept individuals with diabetes. It says people with prediabetes or hypertension are welcome to be considered, but that does not guarantee acceptance. The provider’s other exclusions and individual physician evaluation still apply. Its criteria are service-specific and should not be treated as a general conclusion about which treatments another clinician might discuss.

Sources: [5]

Can Willow send the prescription to my own pharmacy?

Its FAQ says yes, provided that pharmacy can fill the compound exactly as written. However, Willow then charges a platform fee and the patient pays the outside pharmacy directly for medication. The public material reviewed does not quantify that platform fee. Obtain a combined cost estimate and confirm the pharmacy’s ability to prepare the prescription before assuming this route is interchangeable with Willow’s bundled offer.

Sources: [6]

Will my insurance reimburse Willow payments?

The documentation does not provide a reliable yes. The help center discusses possible reimbursement after submitting receipts, but the terms say patients agree not to submit claims to government programs or other third-party payors. Willow does not bill insurance directly. Resolve that conflict with Willow in writing and confirm any potential coverage separately with the plan before relying on reimbursement.

Sources: [3] [4]

Does canceling Willow automatically produce a refund?

No. The FAQ separates the renewal cutoff from refund eligibility. Avoiding the next charge requires notice at least two business days before the processing date. The stated full-refund condition is cancellation before the prescription is sent to the pharmacy, with a described five-to-ten-business-day window. Ask for confirmation of both the subscription cancellation and any refund decision; neither should be inferred from the other.

Sources: [6]

Our assessment

Willow documents more than a headline offer: it provides formulation-specific pricing, physician messaging, named pharmacy partners and a concrete cancellation cutoff. Those details help a prospective patient prepare a meaningful consultation. They do not resolve every decision. Before enrolling, obtain the exact prescription and monthly quote, the treating practice and dispensing pharmacy, a follow-up plan, and the next processing date. The insurance contradiction deserves written clarification, and the combination tablet deserves a specific evidence discussion with the prescriber. Willow is best assessed as a documented online access pathway with unresolved operational and contractual questions—not as proof of a particular clinical outcome or a universally $299 treatment.

Visit Willow (startwillow.com)’s official site ↗

This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.

Sources & documentation

Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.

Willow Review: Questions to Settle Before Starting a GLP-1 Subscription

At a glance

01Start with the exact medicine, not just the GLP-1 label

02Ask who is responsible for each part of care

03Clarify screening before treating payment as acceptance

04Get a prescription-specific monthly quote

05Resolve the insurance contradiction before relying on reimbursement

06Separate medical review, pharmacy processing and delivery

07Define what ongoing support means in practice

08Put the next processing date on your decision checklist